Tevogen (TVGN) Accumulated Expenses (2023 - 2026)

Tevogen Bio Holdings (TVGN) has 4 years of Accumulated Expenses data on file, last reported at $1.2 million in Q1 2026.

• Quarterly Accumulated Expenses fell 37.42% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 37.42% YoY) and the FY2025 annual result came in at $1.5 million, down 12.43% from the prior year.
• Accumulated Expenses retreated to $1.2 million in Q1 2026, from $1.5 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $2.0 million in Q1 2025 to a low of $1.1 million in Q4 2023.
• A 4-year average of $1.5 million and a median of $1.5 million in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Accumulated Expenses jumped 56.18% — and 2026, when it sank 37.42%.
• Tracing TVGN's Accumulated Expenses over 4 years: stood at $1.1 million in 2023, then jumped by 56.18% to $1.7 million in 2024, then fell by 12.43% to $1.5 million in 2025, then decreased by 17.23% to $1.2 million in 2026.
• The last three Accumulated Expenses figures came in at $1.2 million (Q1 2026), $1.5 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.